METTL3 and hepatocellular carcinoma: In hepatocellular carcinoma, it was shown that METTL3-mediated N6-methyladenosine modification leads to upregulation of LINC00958, which uptakes miR3619-5p and thus upregulates HDGF expression, which facilitates adipogenesis and advancement of HCC.